|Last Updated: September 18, 2019 @ 9:13 am|
Cardiovascular Disease Risk Panel + Apolipoprotein B
|Stability:||Ambient: Unacceptable; Refrigerated: 3 Day(s); Frozen: 3 Month(s); Incubated: Unacceptable|
|Interpretive Data:||Please see report for interpretive data.|
LDL Direct Pediatric Reference Range (under age 19 years):
<110 mg/dL - Desirable
110-129 mg/dL - Borderline
>129 mg/dL - High
LDL Direct Adult Reference Range:
<100 mg/dL - Optimal
110-129 mg/dL - Near Optimal
130-159 mg/dL - Borderline High
160-189 mg/dL - High
Executive Summary of the Third Report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA May, 2001.
The NCEP recommends that dietary and/or drug treatment not be initiated based on a single LDL Cholesterol result.
In cases where triglyceride levels are high (>150 mg/dL), LDL calculations underestimate true LDL levels. Thus, direct measurement of LDL is more accurate and of increased importance in patients with high risk of cardiovascular disease (CVD).
Elevated levels of Lipoprotein(a) are associated with increased risk of cardiovascular disease (CVD).
Elevated levels of Apolipoprotein B (ApoB) are associated with increased risk of cardiovascular disease, even when LDL or non-HDL levels are within normal limits.